Interestingly, in patients with HF, inferior outcomes might be due to both an increased risk of non-relapse/progression mortality related to more frequent cardiovascular deaths and an increased incidence of relapse/progression, although the p values for both events did not reach statistical significance.
← all excerpts
Type 2 diabetes mellitus compromises the survival of diffuse large B-cell lymphoma patients treated with (R)-CHOP - the PLRG report.
1
—
—